Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PI3K/AKT/MTOR: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | PI3K/AKT/MTOR |
| Related Diseases | triple-negative breast cancer, Glioblastoma, drug resistance |
Knowledge base pages for this entity
graph TD
PI3K_AKT_MTOR["PI3K/AKT/MTOR"]
style PI3K_AKT_MTOR fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
PI3K_AKT_MTOR -->|"regulates"| Insulin_Resistance(Insulin Resistance)
PI3K_AKT_MTOR -->|"involved_in"| Glioblastoma["Glioblastoma"]
PI3K_AKT_MTOR -->|"regulates"| Cell_Proliferation["Cell Proliferation"]
PI3K_AKT_MTOR -->|"regulates"| Cell_Survival["Cell Survival"]
PI3K_AKT_MTOR -->|"activates"| multiple_myeloma["multiple myeloma"]
PI3K_AKT_MTOR -->|"involved_in"| Hormone_Receptor_Positive_Brea["Hormone Receptor-Positive Breast Cancer"]
PI3K_AKT_MTOR -->|"involved_in"| Breast_Cancer["Breast Cancer"]
PI3K_AKT_MTOR -->|"involved_in"| Colorectal_Cancer["Colorectal Cancer"]
PI3K_AKT_MTOR -->|"activates"| Triple_Negative_Breast_Cancer["Triple-Negative Breast Cancer"]
Gomisin_N["Gomisin N"] -->|"activates"| PI3K_AKT_MTOR
Paxalisib{"Paxalisib"} -.->|"inhibits"| PI3K_AKT_MTOR
Cordycepin["Cordycepin"] -.->|"inhibits"| PI3K_AKT_MTOR
Capivasertib{"Capivasertib"} -.->|"inhibits"| PI3K_AKT_MTOR
Alpelisib{"Alpelisib"} -.->|"inhibits"| PI3K_AKT_MTOR
SYK([SYK]) -->|"regulates"| PI3K_AKT_MTOR
MTOR([MTOR]) -->|"component_of"| PI3K_AKT_MTOR
BBR{"BBR"} -.->|"inhibits"| PI3K_AKT_MTOR
Polygonatum_sibiricum_polysacc["Polygonatum sibiricum polysaccharide"] -->|"activates"| PI3K_AKT_MTOR
Ly294002{"Ly294002"} -.->|"inhibits"| PI3K_AKT_MTOR| Target | Relation | Type | Str |
|---|---|---|---|
| Glioblastoma Metabolism | upregulates | process | 0.93 |
| cell proliferation | regulates | process | 0.93 |
| triple-negative breast cancer | promotes | disease | 0.92 |
| ferritinophagy | regulates | process | 0.90 |
| myeloma cell proliferation | activates | process | 0.90 |
| myeloma cell survival | promotes | process | 0.90 |
| triple-negative breast cancer | regulates | disease | 0.90 |
| angiogenesis | promotes | process | 0.90 |
| Glioblastoma | upregulates | disease | 0.90 |
| Lipid Metabolism | regulates | process | 0.90 |
| drug resistance | promotes | phenotype | 0.85 |
| Glycolytic Flux | associated_with | process | 0.85 |
| Ferroptosis | regulates | process | 0.85 |
| Ovarian Follicle | activates | cell_type | 0.85 |
| Endometriosis-Associated Ovarian Cancer | involved_in | disease | 0.80 |
| GBM | regulates | disease | 0.70 |
| DENTATE GYRUS | associated_with | brain_region | 0.50 |
| PHAGOCYTOSIS | associated_with | phenotype | 0.50 |
| SYK | associated_with | gene | 0.50 |
| ALZHEIMER | associated_with | disease | 0.50 |
| PDGF | associated_with | gene | 0.50 |
| KEAP1 | associated_with | gene | 0.50 |
| NRF2 | associated_with | gene | 0.50 |
| GLYCOLYSIS | associated_with | phenotype | 0.45 |
| PTEN | associated_with | gene | 0.45 |
| AKT | associated_with | gene | 0.45 |
| FERROPTOSIS | associated_with | phenotype | 0.45 |
| LIPOGENESIS | associated_with | phenotype | 0.45 |
| APOPTOSIS | associated_with | phenotype | 0.45 |
| BCL2 | associated_with | gene | 0.45 |
| BAX | associated_with | gene | 0.45 |
| ROS | associated_with | phenotype | 0.45 |
| CELL DEATH | associated_with | phenotype | 0.45 |
| SLC7A11 | associated_with | gene | 0.45 |
| GPX4 | associated_with | gene | 0.45 |
| TUMOR GROWTH | associated_with | phenotype | 0.45 |
| PIK3CA | associated_with | gene | 0.45 |
| CYTOKINES | associated_with | phenotype | 0.45 |
| FIBROSIS | associated_with | disease | 0.45 |
| AUTOPHAGY | associated_with | phenotype | 0.45 |
| SNAP25 | associated_with | gene | 0.45 |
| CURCUMIN | associated_with | drug | 0.45 |
| PARKINSON | associated_with | disease | 0.45 |
| TH | associated_with | gene | 0.45 |
| NEURONS | associated_with | cell_type | 0.45 |
| MAPK | associated_with | gene | 0.45 |
| STRIATUM | associated_with | brain_region | 0.45 |
| ERK | associated_with | gene | 0.45 |
| JNK | associated_with | gene | 0.45 |
| PYRUVATE | associated_with | phenotype | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Ginsenoside Rg3 | inhibits | compound | 0.85 |
| Cantharidin | inhibits | compound | 0.85 |
| bone marrow microenvironment | activates | cell_type | 0.82 |
| THBS2 | activates | gene | 0.80 |
| INSULIN_RESISTANCE | impairs | phenotype | 0.80 |
| SYK | causes | gene | 0.70 |
| LIPOGENESIS | regulates | phenotype | 0.65 |
| SARCOPENIA | targets | disease | 0.65 |
| ROS | phosphorylates | phenotype | 0.65 |
| ROS | activates | phenotype | 0.65 |
| ROS | regulates | phenotype | 0.65 |
| SLC7A11 | inhibits | gene | 0.65 |
| CYTOKINES | inhibits | phenotype | 0.65 |
| FIBROSIS | inhibits | disease | 0.65 |
| TUMOR GROWTH | inhibits | phenotype | 0.65 |
| FERROPTOSIS | targets | phenotype | 0.65 |
| PARKINSON'S DISEASE | inhibits | disease | 0.65 |
| APOPTOSIS | inhibits | phenotype | 0.65 |
| PYRUVATE | inhibits | phenotype | 0.65 |
| PYRUVATE | regulates | phenotype | 0.65 |
| FIBROBLASTS | inhibits | cell_type | 0.65 |
| LIPID METABOLISM | inhibits | phenotype | 0.65 |
| LIPID METABOLISM | associated_with | phenotype | 0.50 |
| CELL PROLIFERATION | associated_with | phenotype | 0.45 |
| IRON ACCUMULATION | associated_with | phenotype | 0.45 |
| NEUROINFLAMMATION | associated_with | phenotype | 0.45 |
| SUBSTANTIA NIGRA | associated_with | brain_region | 0.45 |
| DRUG RESISTANCE | associated_with | phenotype | 0.45 |
| INSULIN RESISTANCE | associated_with | phenotype | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||